James Bay Lithium (ASX:JBY): Why has it been running so hot this week?

Nick Sundich Nick Sundich, September 14, 2023

James Bay Lithium (ASX:JBY) is more than double its IPO price in less than a week of trading. Why is it running so hot in an IPO market that has been bearish for nearly two years now?


What are the Best stocks to invest in right now?

Check our buy/sell stock tips



Why investors want a piece of James Bay Lithium (ASX:JBY)

You might have guessed it is because of a lithium stock that has potential for a discovery. The company is named after James Bay in Canada where its ~224km squared portfolio lies. It is right near the deposits of other ASX lithium players including Patriot Battery Metals (ASX:PMT) and Sayona (ASX:SYA) which have a resource of over 160Mt @ 1.3% lithium.

Investors think the company could have a significant resource at its project and re-rate as it is unlocked.


Should I buy it?

It all depends on whether or not you are comfortable with the risks of early stage explorers. This is particularly true for companies such as James Bay Lithium that have run hot immediately post-IPO. If the company can discover some lithium, investors who got in at IPO will make even more money. But if it cannot, there’ll be major losses.


Stocks Down Under Concierge is here to help you pick winning stocks!

The team at Stocks Down Under have been in the markets since the mid-90s and we have gone through many ups and downs. We have written about every sector!

Our Concierge BUY and SELL service picks the best stocks on ASX. We won’t just tell you what to buy – we give you a buy range, price target and stop loss level in order to maximise total returns. And we will only recommend very high conviction stocks where substantial due diligence has been conducted.

Our performance is well ahead of the ASX200 and All Ords.

You can try out Conciergefor FREE.




There’s no credit card needed – the trial expires automatically.



Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts


Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…